CD8A and breast carcinoma: In breast cancer patients, increased infiltration of CD4+ helper T lymphocytes, CD8+ cytotoxic T lymphocytes, B lymphocytes, M1 macrophages, and NK cells is associated with improved progression-free survival (PFS) and overall survival (OS) [76,77,78].